Filing Details

Accession Number:
0001193805-12-001149
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-09 19:07:54
Reporting Period:
2012-07-05
Filing Date:
2012-07-09
Accepted Time:
2012-07-09 19:07:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1140028 Talon Therapeutics Inc. TLON.OB Pharmaceutical Preparations (2834) 320064979
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1009258 Deerfield Management Co /Ny 780 Third Avenue, 37Th Floor
New York NY 10017
No No Yes Yes
1010823 Deerfield Capital Lp 780 Third Avenue
37Th Floor
New York NY 10017
No No Yes Yes
1352546 E James Flynn 780 Third Avenue
37Th Floor
New York NY 10017
Yes No Yes Yes
1354395 Deerfield Special Situations Fund, L.p. 780 3Rd Avenue
37Th Floor
New York NY 10017
No No Yes Yes
1354397 Ltd International Fund Situations Special Deerfield C/O Citi Hedge Fund Services (Bvi) Ltd
Bison Court, P.o. Box 3460
Road Town, Tortola D8 -
No No Yes Yes
1397526 P L Fund Design Private Deerfield 780 3Rd Ave 37Th Fl
New York NY 10017
No No Yes Yes
1407589 Deerfield Private Design International, L.p. 780 Third Avenue, 37Th Floor
New York NY 10017
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-07-05 57,165 $1.22 34,252 No 4 S Indirect Through Deerfield Special Situations Fund, L.P.
Common Stock Disposition 2012-07-05 112,693 $1.22 67,524 No 4 S Indirect Through Deerfield Special Situations Fund International, Limited
Common Stock Disposition 2012-07-05 141,750 $1.22 84,934 No 4 S Indirect Through Deerfield Private Design Fund, L.P.
Common Stock Disposition 2012-07-05 228,392 $1.22 136,849 No 4 S Indirect Through Deerfield Private Design International, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Through Deerfield Special Situations Fund, L.P.
No 4 S Indirect Through Deerfield Special Situations Fund International, Limited
No 4 S Indirect Through Deerfield Private Design Fund, L.P.
No 4 S Indirect Through Deerfield Private Design International, L.P.
Footnotes
  1. This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). The Capital Funds and the Management Fund (each as defined below) share a contractual right to designate one director to the Board of Directors of the Company and are directors-by-deputization solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
  2. Deerfield Capital, L.P. is the general partner of Deerfield Special Situations Fund, L.P., Deerfield Private Design Fund, L.P. and Deerfield Private Design International, L.P. (the "Capital Funds"). James E. Flynn is the managing member of the general partner of Deerfield Capital, L.P. In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Capital Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
  3. Deerfield Management Company, L.P. is the investment manager of Deerfield Special Situations Fund International, Limited (the "Management Fund"). James E. Flynn is the managing member of the general partner of Deerfield Management Company, L.P. In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Management Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.